Dentsply Sirona Reports Preliminary Q3 Net Sales Of Approximately $951M (Est $937.91M) And Adjusted EPS Of $0.49 - $0.51 (Est $0.47)
Portfolio Pulse from Benzinga Newsdesk
Dentsply Sirona reports preliminary Q3 net sales of $951M, exceeding estimates. Adjusted EPS is expected between $0.49 and $0.51, also above estimates. The company anticipates sales growth in Essential Dental Solutions but declines in Orthodontic and Implant Solutions. Non-cash charges for goodwill impairment in Orthodontic Aligner Solutions and Implants & Prosthetic Solutions are expected, due to reduced revenue forecasts and lower operating margins.
October 24, 2024 | 9:40 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Dentsply Sirona's preliminary Q3 results show net sales of $951M, surpassing estimates. Adjusted EPS is expected to be $0.49-$0.51, above the estimated $0.47. The company anticipates growth in Essential Dental Solutions but declines in Orthodontic and Implant Solutions. A goodwill impairment charge of $450-$550M is expected due to reduced revenue forecasts and lower operating margins.
Dentsply Sirona's preliminary Q3 results exceed sales and EPS estimates, which is positive. However, the expected goodwill impairment of $450-$550M due to reduced revenue forecasts and lower operating margins in key segments offsets this positivity. The mixed results suggest a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100